Literature DB >> 19876893

Allelic loss of chromosomes 8 and 19 in MENX-associated rat pheochromocytoma.

Alena Shyla1, Gabriele Hölzlwimmer, Julia Calzada-Wack, Karin Bink, Oleg Tischenko, Marie-Noëlle Guilly, Sylvie Chevillard, Elenore Samson, Jochen Graw, Michael J Atkinson, Natalia S Pellegata.   

Abstract

Pheochromocytomas are neoplasias of neural crest origin that arise from the chromaffin cells of the adrenal medulla. Pheochromocytomas arise with complete penetrance in rats homozygous for a germ-line frameshift mutation of Cdkn1b, encoding the cell cycle inhibitor p27KIP1 (MENX syndrome). We performed a genome-wide scan for allelic imbalance comparing 20 rat pheochromocytoma DNAs with normal rat DNA to better understand the pathobiology of the tumors and to correlate the findings with human pheochromocytoma. We identified allelic imbalance (AI) at candidate regions on rat chromosomes 8 and 19. Interestingly, the regions often lost in rat tumors are syntenic to regions involved in human pheochromocytomas. Fluorescence in situ hybridization analysis further validated the AI data. Sdhd and Rassf1a were analyzed in detail as they map to regions of AI on chromosome 8 and their homologues are implicated in human pheochromocytoma: we found no genetic mutations nor decreased expression. We also analyzed additional candidate genes, that is, rat homologues of genes predisposing to human pheochromocytoma and known tumor-suppressor genes, but we found no AI. In contrast, we observed frequent overexpression of Cdkn2a and Cdkn2c, encoding the cell cycle inhibitors p16INK4a and p18INK4c, respectively. The relative small number of allelic changes we found in rat pheochromocytoma might be related to their nonmalignant status and losses at chromosomes 8 and 19 are events that precede malignancy. Because of the high concordance of affected loci between rat and human tumors, studies of the MENX-associated pheochromocytomas should facilitate the identification of novel candidate genes implicated in their human counterpart.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19876893     DOI: 10.1002/ijc.24925

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.

Authors:  Sara Molatore; Sandya Liyanarachchi; Martin Irmler; Aurel Perren; Massimo Mannelli; Tonino Ercolino; Felix Beuschlein; Barbara Jarzab; Jan Wloch; Jacek Ziaja; Saida Zoubaa; Frauke Neff; Johannes Beckers; Heinz Höfler; Michael J Atkinson; Natalia S Pellegata
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 2.  Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?

Authors:  Esther Korpershoek; Karel Pacak; Lucia Martiniova
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

3.  A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.

Authors:  Sara Molatore; Ilaria Marinoni; Misu Lee; Elke Pulz; Maria Rosaria Ambrosio; Ettore C degli Uberti; Maria Chiara Zatelli; Natalia S Pellegata
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

4.  Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.

Authors:  Ines Leinhäuser; Andrea Richter; Misu Lee; Ines Höfig; Nataša Anastasov; Falko Fend; Tonino Ercolino; Massimo Mannelli; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo; Ronald de Krijger; Felix Beuschlein; Michael J Atkinson; Natalia S Pellegata
Journal:  Oncotarget       Date:  2015-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.